PubRank

B Bonavida

Author PubWeight™ 179.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006 4.06
2 Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency. J Immunol 1979 1.80
3 Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy 2011 1.73
4 Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 2001 1.59
5 Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. Clin Cancer Res 2001 1.59
6 Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988 1.54
7 Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol 1995 1.53
8 Human tear lysozyme. II. Quantitative determination with standard Schirmer strips. Am J Ophthalmol 1968 1.46
9 Evidence for several cell populations active in antibody dependent cellular cytotoxicity. J Immunol 1973 1.44
10 Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells. J Immunol 1982 1.42
11 Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm 1997 1.40
12 Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J Immunol 1992 1.39
13 Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. J Immunol 1986 1.34
14 Cellular immunoadsorbents: a simplified technique for separation of lymphoid cell populations. J Immunol 1974 1.34
15 Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 2009 1.34
16 Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Curr Cancer Drug Targets 2011 1.33
17 The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype. J Exp Med 1988 1.30
18 Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J Immunol 1996 1.30
19 Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate. J Immunol 1979 1.29
20 Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes. J Immunol 1981 1.26
21 Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibition. J Biol Chem 1989 1.25
22 Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps. J Immunol 1980 1.25
23 Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol 1999 1.24
24 Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. Eur J Cancer 2002 1.22
25 Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis. J Immunol 1980 1.21
26 Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. J Immunol 1987 1.15
27 Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res 1995 1.15
28 Histamine-receptor leucocytes (HRL). Organ and lymphoid subpopulation distribution in man. Clin Exp Immunol 1977 1.13
29 Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes. J Exp Med 1977 1.13
30 Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anticancer Agents 2003 1.13
31 Histamine receptor-bearing leukocytes (HRL). I. Detection of histamine receptor-bearing cells by rosette formation with histamine-coated erythrocytes. J Immunol 1974 1.13
32 Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells. J Immunol 1983 1.13
33 Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. J Immunol 1990 1.13
34 Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J Immunol 1997 1.11
35 Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset. Cell Immunol 1995 1.11
36 Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells. J Clin Immunol 1988 1.07
37 Lectin-dependent cellular cytotoxicity in man. Transplantation 1977 1.06
38 Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis. Oncogene 2007 1.04
39 Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells. J Clin Immunol 1995 1.04
40 Antibody dependent cellular cytotoxicity: cytotoxicity mediated by non t-lymphocytes. Clin Immunol Immunopathol 1974 1.03
41 Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J Immunol 2001 1.03
42 Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines. J Immunol 1991 1.03
43 Specific antibodies to dinucleotides and trinucleotides. Eur J Biochem 1972 1.02
44 Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay. J Immunol 1982 1.02
45 Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis. Oncogene 2006 1.02
46 Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochem Biophys Res Commun 1999 1.02
47 The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol Immunother 1997 1.01
48 Proteins in human tears. I. Immunoelectrophoretic patterns. Arch Ophthalmol 1969 0.99
49 Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens. Cancer Res 1976 0.99
50 2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model. Clin Immunol 2008 0.98
51 Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF). J Immunol 1987 0.98
52 Prolonged asymptomatic states in HIV-seropositive persons with 50 CD4+ T-cells/mm3: preliminary psychoimmunologic findings. J Acquir Immune Defic Syndr 1993 0.97
53 Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity. Cancer 1999 0.97
54 Mechanism of cell-mediated cytotoxicity at the single cell level. VIII. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte. J Immunol 1984 0.96
55 Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide. Cancer 1994 0.96
56 Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia 2008 0.96
57 Human tear lysozyme. 3. Preliminary study on lysozyme levels in subjects with smog eye irritation. Am J Ophthalmol 1968 0.96
58 Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res 1993 0.95
59 Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. J Immunol 1999 0.95
60 Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells. Cell Immunol 1982 0.95
61 Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets. Proc Natl Acad Sci U S A 1990 0.94
62 Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin. Int J Oncol 1998 0.94
63 The SJL/J spontaneous reticulum cell sarcoma: new insights in the fields of neoantigens, host-tumor interactions, and regulation of tumor growth. Adv Cancer Res 1983 0.93
64 CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol 2000 0.93
65 Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Cancer Res 1995 0.93
66 Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation. J Clin Immunol 1996 0.92
67 Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells. Clin Cancer Res 1999 0.92
68 Frequency determination of killer cells by a single-cell cytotoxic assay. Methods Enzymol 1983 0.92
69 Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis. Clin Cancer Res 1997 0.92
70 Immunological unresponsiveness induced in adult mice to synthetic polypeptides built on multichain polyproline and multichain polyalanine. Immunochemistry 1974 0.92
71 Autoimmunity and aging: the age-related response of mice of a long-lived strain to trinitrophenylated syngeneic mouse red blood cells. J Immunol 1976 0.92
72 Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens. J Immunol 1974 0.91
73 Direct estimation of frequency of cytotoxic T lymphocytes by a modified plaque assay. Nature 1976 0.91
74 Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). J Immunol 1983 0.91
75 MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha. Clin Immunol 2000 0.90
76 Human tear lysozyme. I. Purification, physicochemical, and immunochemical characterization. J Lab Clin Med 1967 0.90
77 Studies on the induction and expression of T cell-mediated immunity. VIII. Effector-target junctions and target cell membrane disruption during cytolysis. Cell Immunol 1979 0.90
78 Studies on the induction and expression of T cell-mediated immunity. XII. The concomitant loss and recovery of membrane-associated Lyt-2 antigens, lymphocyte-target cell binding, and the antigen-specific and -nonspecific cytotoxic activity of alloimmune T lymphocytes after treatment with trypsin. J Immunol 1981 0.90
79 Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. J Urol 2001 0.90
80 Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor. J Immunol 1987 0.89
81 Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecol Oncol 1999 0.89
82 Capacity of tumor necrosis factor to bind and penetrate membranes is pH-dependent. J Immunol 1988 0.89
83 Antibody-mediated in vivo suppression of EL4 leukemia in a syngeneic host. J Natl Cancer Inst 1974 0.89
84 HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice. Virology 1996 0.89
85 Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytes. J Immunol 1981 0.89
86 Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens. J Immunol 1975 0.88
87 Mechanism of cell-mediated cytotoxicity at the single cell level. III. Evidence that cytotoxic T lymphocytes lyse both antigen-specific and -nonspecific targets pretreated with lectins or periodate. J Immunol 1981 0.88
88 Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis. J Immunother 2001 0.87
89 Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase. Gynecol Oncol 2001 0.87
90 Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells. J Clin Immunol 1986 0.87
91 Structural basis for immune recognition of lysozymes. I. Effect of cyanogen bromide on hen egg-white lysozyme. Biochemistry 1969 0.87
92 Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis. J Immunol 1974 0.87
93 Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity. Cell Immunol 1997 0.87
94 Immune functions characteristic of SJL/J mice and their association with age and spontaneous reticulum cell sarcoma. Cancer Res 1976 0.87
95 Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization. J Urol 1994 0.87
96 Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes. J Exp Med 1981 0.87
97 Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis. Clin Cancer Res 2001 0.87
98 Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells. J Immunol 1985 0.87
99 Studies on the induction and expression of T cell-mediated immunity. V. Lectin-induced nonspecific cell-mediated cytotoxicity by alloimmune lymphocytes. Transplantation 1976 0.86
100 Prognostic significance of soluble Fas in the serum of patients with bladder cancer. J Urol 1998 0.86
101 Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Int J Oncol 2000 0.86
102 Preferential induction of TNF-alpha and IL-1beta and inhibition of IL-10 secretion by human peripheral blood monocytes by synthetic aza-alkyl lysophospholipids. Cell Immunol 1999 0.86
103 Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha. Nat Immun 1992 0.86
104 Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system. J Immunol 1997 0.86
105 Nitric oxide disrupts H2O2-dependent activation of nuclear factor kappa B. Role in sensitization of human tumor cells to tumor necrosis factor-alpha -induced cytotoxicity. J Biol Chem 2000 0.85
106 Immune response of New Zealand mice to trinitrophenylated syngeneic mouse red cells. Eur J Immunol 1976 0.85
107 Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity. J Immunol 1986 0.85
108 CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model. Transplantation 2001 0.85
109 Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity. Cancer 1997 0.85
110 Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion. Cell Immunol 1994 0.85
111 Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab. Anticancer Res 2000 0.85
112 Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res 1996 0.85
113 Studies of the induction and expression of T cell mediated immunity. VI. Heterogeneity of lytic efficiency exhibited by isolated cytotoxic T lymphocytes prepared from highly enriched populations of effector-target conjugates. J Immunol 1977 0.84
114 Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC). Clin Immunol Immunopathol 1990 0.84
115 Studies on the induction and expression of T cell-mediated immunity. VII. Inactivation of autologous cytotoxic T lymphocytes when used as both effectors and targets in a lectin-dependent cellular cytotoxic reaction. Transplantation 1978 0.84
116 Frequency determination of K cells by a single cell cytotoxic assay. J Immunol Methods 1980 0.84
117 Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay. Cell Immunol 1984 0.84
118 Analysis of lymphocyte-target conjugates by flow cytometry. I. Discrimination between killer and non-killer lymphocytes bound to targets and sorting of conjugates containing one or multiple lymphocytes. Nat Immun Cell Growth Regul 1986 0.84
119 Antigen-induced cyclophosphamide-resistant suppressor T cells inhibit the in vitro generation of cytotoxic cells from one-way mixed leukocyte reactions. J Immunol 1977 0.83
120 Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation. J Immunol 1987 0.83
121 Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens. Transplant Proc 1979 0.83
122 Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype. Gynecol Oncol 1993 0.82
123 Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells. Cancer 1989 0.82
124 A single cell marker of active NK cytotoxicity: only a fraction of target binding lymphocytes are killer cells. J Clin Lab Immunol 1980 0.82
125 Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum. Cancer 1996 0.82
126 Antibodies to transfer RNA obtained with covalently linked tRNA conjugates. Biochem Biophys Res Commun 1970 0.82
127 YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 1983 0.82
128 Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes. J Immunol 1986 0.81
129 Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432. Cancer Immunol Immunother 1988 0.81
130 Irreversible cancer cell-induced functional anergy and apoptosis in resting and activated NK cells. Int J Oncol 1999 0.81
131 Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). J Immunol 1983 0.81
132 Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis. Prostate 1999 0.81
133 Preface: antibody therapies for cancer. Oncogene 2007 0.81
134 Pivotal role of endogenous TNF-alpha in the IL-2-driven activation and proliferation of the functionally immature NK free subset. Cell Immunol 1993 0.81
135 Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells. J Immunol 1999 0.81
136 Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo. Cancer Res 1977 0.81
137 Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers. Nat Immun Cell Growth Regul 1990 0.81
138 Expression of inappropriate H-2 antigens on SJL reticulum cell tumors. Transplant Proc 1979 0.81
139 Strain-dependent differences in susceptibility of mice to experimental pyelonephritis. J Infect Dis 1985 0.80
140 Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion. J Clin Immunol 1994 0.80
141 Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells. J Immunol 1986 0.80
142 Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines. Urol Res 1994 0.80
143 Heterogenous populations of cytotoxic cells in the peritoneal cavity of BALB/c mice immunized with allogeneic EL4 leukemia cells. Cell Immunol 1974 0.80
144 Calcium-independent pathway of tumor necrosis factor-mediated lysis of target cells. J Immunol 1989 0.80
145 Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification. J Immunol 1987 0.80
146 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature. Prostate Cancer Prostatic Dis 1999 0.80
147 Inhibition of IA positive reticulum cell sarcoma tumor cell growth in syngeneic SJL/J mice by passive administration of monoclonal anti-IA antibody. Cancer Res 1986 0.80
148 Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor. Anticancer Res 1999 0.80
149 Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells. Cancer 1993 0.79
150 Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil. Oncol Rep 1999 0.79
151 Molecular pathogenesis of AIDS-associated Kaposi's sarcoma: growth and apoptosis. Adv Cancer Res 2000 0.79
152 Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells. Cell Immunol 1986 0.79
153 Studies on the induction and expression of T cell-mediated immunity. IX. Activation of alloimmune memory lymphocytes into specific secondary CTL by syngeneic NAGO-oxidized stimulator cells. J Immunol 1979 0.79
154 Non-H-2-linked control of in vivo growth of SJL/J-derived reticulum cell sarcoma in recombinant inbred strains between BALB/cKe and SJL/J mice. J Natl Cancer Inst 1985 0.79
155 Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines. Anticancer Res 1999 0.79
156 Specific tear prealbumin: a unique lachrymal protein absent from serum and other secretions. Nature 1969 0.79
157 Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas. Cancer Res 1983 0.79
158 Autoreactive antibody-forming cells directed against thymocytes and thymus-derived lymphocytes. J Immunol 1978 0.79
159 Initiation and characterization of cultured tumor lines from spontaneous reticulum cell sarcoma of SJL/J mice. Cancer Res 1977 0.79
160 Molecular interactions in T-cell-mediated cytotoxicity. Immunol Rev 1983 0.78
161 Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates. J Immunol 1984 0.78
162 Murine spleen lymphocytes bearing receptors for peanut agglutinin. VII Separation and functional characterization. Cell Immunol 1981 0.78
163 Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role. Transplant Proc 1980 0.78
164 Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha. Cancer 1993 0.78
165 Inappropriate alloantigen-like specificities detected on spontaneous and transplantable reticulum cell sarcomas of SJL/J mice. J Immunogenet 1980 0.78
166 Rabbit tear proteins. I. Detection and quantitation of lysozyme in nonstimulated tears. Invest Ophthalmol 1968 0.78
167 Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells. Cancer Chemother Pharmacol 1990 0.78
168 Circumvention of tumor cell escape following specific immunotherapy. Cancer Biother Radiopharm 2000 0.78
169 Modulation of the immune response toward allografts in vivo. I. Selective suppression of the development of cell-mediated immunity by soluble alloantigens. Cell Immunol 1974 0.78
170 Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance. Cancer Res 1992 0.77
171 Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. J Clin Immunol 1994 0.77
172 Sequential appearance of antibodies directed against different antigenic determinants of hen egg-white lysozyme. Eur J Immunol 1971 0.77
173 The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy. J Immunol 1989 0.77
174 Transplantation of allogeneic lymphoid cells specifically depleted of graft versus host reactive cells. Nature 1974 0.77
175 Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding. J Immunol 1986 0.77
176 Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). J Urol 1998 0.77
177 Structural basis for immune recognition of lysozymes. II. Reactive but non-immunogenic epitopes. Eur J Immunol 1971 0.77
178 Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen. Transplantation 1974 0.77
179 Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine. Neuroimmunomodulation 1995 0.76
180 Antibacterial activity of adriamycin against bacillus Calmette-Guerin. Oncol Rep 2011 0.76
181 Lysis of uninfected HIV-1 gp120-coated peripheral blood-derived T lymphocytes by monocyte-mediated antibody-dependent cellular cytotoxicity. FEMS Immunol Med Microbiol 1995 0.76
182 Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity. Adv Exp Med Biol 1982 0.76
183 Sensitization of AIDS related non-Hodgkin's B lymphoma cell lines to cytotoxic drugs toxins by interferon-gamma. Int J Oncol 1996 0.76
184 Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC). J Immunol 1985 0.76
185 A comparative study of intravenous versus intralymphatic interleukin-2, with assessment of effects of interleukin-2 on both peripheral blood and thoracic-duct lymph. J Immunother Emphasis Tumor Immunol 1994 0.76
186 Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell lines. Anticancer Res 1992 0.76
187 Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis. Gynecol Oncol 1996 0.76
188 Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation. Transplant Proc 1977 0.76
189 Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures. J Immunol 2001 0.75
190 Structural basis for immune recognition of lysozymes. IV. Immunologically active peptide obtained by the action of cyanogen bromide on human lysozyme. Immunochemistry 1971 0.75
191 Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors. Nat Immun Cell Growth Regul 1985 0.75
192 Opsonization of antitumor reactive lymphocyte in SJL/J mice bearing spontaneous or transplanted reticulum cell sarcomas (RCS). Adv Exp Med Biol 1979 0.75
193 Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines. Cancer Chemother Pharmacol 1993 0.75
194 Molecular mechanism of natural killer cell-mediated cytotoxicity. Adv Exp Med Biol 1987 0.75
195 Detection and characterization of lymphocytes bearing receptors for peanut agglutinin by a specific rosetting technique. J Immunol Methods 1981 0.75
196 Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines. J Immunol 1984 0.75
197 Use of a self-generating percoll gradient and single cell cytotoxicity assay to identify tumor-lytic properties of inflammatory neutrophils. J Immunol Methods 1985 0.75
198 Cross-reactivity of some rabbit anti-human lysozyme sera with gallinaceous lysozymes. Biochim Biophys Acta 1971 0.75
199 Predictors of natural killer cell-mediated cytotoxicity deficiency in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997 0.75
200 Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitro. Int J Immunopharmacol 1985 0.75
201 Regulation of reticulum cell sarcoma tumor growth in SJL/J mice by a serum inhibitor affecting T-cell proliferation. Cancer Res 1985 0.75
202 Smog eye irritation: effect of air pollution on the tear protein pattern. Ophthalmologica 1969 0.75
203 Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes. J Immunol 1983 0.75
204 Pentoxifylline enhances sensitivity of a human ovarian cancer cell line (OVC-8) to TNF-alpha. Biotherapy 1995 0.75
205 Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. J Immunol 1993 0.75
206 Opsonization of alloreactive Ly-1+ T cells by antigen-antibody complexes containing free I-A determinants. Transplant Proc 1979 0.75
207 Autoreactive and alloreactive antibody-forming cells (AFC) following lipopolysaccharide (LPS) activation of normal and memory lymphocytes. Transplant Proc 1980 0.75
208 Biochemical characterization of natural killer cytotoxic factors. Adv Exp Med Biol 1985 0.75
209 Studies on the induction and expression of T-cell-mediated immunity. XIII. Membrane-associated antigens of cytotoxic T lymphocytes involved in cytotoxicity. Cell Immunol 1983 0.75
210 Enhancement of skin allograft survival by soluble alloantigen is serum-mediated. Transplantation 1976 0.75
211 Opsonization of tumor-reactive T cells in SJL/J mice bearing syngeneic tumors. Cancer Immunol Immunother 1982 0.75
212 Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells. J Immunol 1974 0.75
213 Expression of superantigen-like specificities on murine sjl/j-B lymphomas - antitumor v-Beta-17a+ T-lymphocytes use a diverse set of T-cell receptor v-alpha-chain gene-sequences. Int J Oncol 1994 0.75
214 Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis. Oncogene 2016 0.75
215 Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers. Anticancer Res 1990 0.75
216 Sensitivity of drug-resistant B-cell lines from AIDS-related non-hodgkins-lymphoma to newly synthesized podophyllotoxin derivatives and aza-alkyllysophospholipids - enhanced sensitization by pretreatment with interferon-gamma. Int J Oncol 1994 0.75
217 Mechanism of T-dependent cytotoxicity: role of papain-sensitive non class I MHC target molecules and expression of target antigen for cytotoxicity. Adv Exp Med Biol 1985 0.75
218 Mechanism of cell-mediated cytotoxicity at the single cell level. V. The importance of target cell structure in cytotoxic T lymphocyte-mediated antigen nonspecific lectin-dependent cellular cytotoxicity. J Immunol 1982 0.75
219 Low toxicity of inhaled interferon-gamma in four patients with lung metastasis from renal cell carcinoma. Oncol Rep 2011 0.75
220 Modulation of T-dependent cell-mediated immune responses by antigen-reactive cell opsonization and active suppression. Transplant Proc 1978 0.75
221 Ricin-mediated cell-lysis and apoptosis of drug sensitive and resistant tumor-cells. Int J Oncol 1993 0.75
222 Enzyme-linked immunosorbent assay for HLA determination on fresh and dried lymphocytes. J Immunol Methods 1983 0.75
223 [quantitative determination of proteins in human tears]. Bull Mem Soc Fr Ophtalmol 1967 0.75
224 Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes. Immunobiology 1987 0.75
225 Mechanism of inhibition of human natural killer activity by ultraviolet radiation. J Immunol 1984 0.75
226 Normal human oral keratinocytes are more sensitive to N-methyl-N'-nitro-N-nitrosoguanidine-induced cytotoxicity and apoptosis than HPV-immortalized oral keratinocytes. Int J Oncol 1997 0.75
227 Liposomes can function as targets for natural killer cytotoxic factor but not for tumor necrosis factor. J Immunol 1989 0.75
228 Anti-inosine antibodies of different specificity produced by immunization with two immunogens. Immunochemistry 1972 0.75
229 RCS tumor-host interactions: tumor growth dependence on L3T4+ T cells and its regulation by suppressor cells. Prog Clin Biol Res 1987 0.75
230 Detection of a transforming gene in spontaneous reticulum cell sarcoma of SJL/J mice: genetically linked and host-dependent neoplasia. Cancer Res 1987 0.75
231 Activation of allosensitized memory lymphocytes into secondary cytotoxic T lymphocytes by third-party stimulator cells: genetic mapping of the stimulating antigens. Transplant Proc 1981 0.75
232 Free-radicals dependent and independent pathways of cddp-mediated cytotoxicity and apoptosis in ovarian tumor-cell lines. Int J Oncol 1995 0.75
233 Cytotoxic activity against resistant human tumor-cell lines by 2 synthetic demethylpodophyllotoxin derivatives - a single stereoisomeric change prevents cell-death by apoptosis. Int J Oncol 1993 0.75
234 Proposal for classification of leukocyte-associated cytolytic molecules: Denver, Colorado, September 28, 1986. J Leukoc Biol 1987 0.75
235 Tears as carriers of antibodies. 1. Presence of antibodies to diverse antigens in rabbit tears. Arch Ophthalmol 1967 0.75
236 Nucleoside-coated bacteriophage T4: a method for the detection and characterization of anti-nucleoside antibodies. J Immunol Methods 1972 0.75
237 Cytotoxicity of new aza-alkyl lysophospholipids against drug-sensitive and resistant human ovarian tumor-cell lines - role of free-radicals and potentiation of cytotoxicity by tnf-alpha and cddp. Oncol Rep 1994 0.75
238 Enhanced susceptibility of c-myc antisense oligonucleotide-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes. J Immunother Emphasis Tumor Immunol 1995 0.75
239 Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice. Leukemia 1993 0.75
240 [TNF and TNF receptors: structure, mechanism of action, role in disease and therapy]. Nihon Rinsho 1993 0.75
241 Both NK sensitive and resistant mycoplasma free cell lines stimulate release of NKCF. Adv Exp Med Biol 1985 0.75
242 Cellular immunoadsorbents. An improved technique for specific depletion of cytotoxic (T) lymphoid cells. J Immunol Methods 1974 0.75
243 Characterization of antibody-mediated inhibition of natural killer (NK) cytotoxicity: evidence for blocking of both recognition and lethal hit stages of cytolysis. Cell Immunol 1983 0.75
244 Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer. Cancer Biother Radiopharm 1996 0.75
245 Bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer. Int J Oncol 1997 0.75
246 Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS). Prog Clin Biol Res 1976 0.75
247 Blocking activity induced by solubilized alloantigens. J Immunol 1974 0.75
248 A sensitive immunoassay for human lysozyme in biological fluids. Biochim Biophys Acta 1971 0.75
249 Overcoming tnf-alpha and cddp resistance of a human ovarian-cancer cell-line (c30) by treatment with buthionine sulfoximine in combination with tnf-alpha and or cddp. Int J Oncol 1993 0.75
250 In vivo and in vitro induction of cytotoxic lymphocytes by alloantigen-reactive lymphocytes fractionated on spleen cell monolayers. Transplantation 1978 0.75
251 Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins. Cancer Immunol Immunother 1992 0.75
252 Use of immunologically modified bacteriophage T4 in detection of antibodies to nucleic acids. Eur J Biochem 1972 0.75
253 Frequency of thymus-dependent plaque-forming units: direct estimation by a modified plaque assay. Transplant Proc 1977 0.75
254 Immunologic control of ovarian cancer. Nat Immun Cell Growth Regul 1988 0.75
255 Molecular interactions in T-cell mediated cytotoxicity: discrimination between the binding and lethal hit stages of cytolysis. Adv Exp Med Biol 1982 0.75
256 Enzyme-linked immunosorbent assay for determination of HLA: gene dose effect. Tissue Antigens 1984 0.75
257 Intimate host-tumor interaction in the spontaneous reticulum cell sarcoma of SJL/J mice: is it an exceptional case? Surv Immunol Res 1985 0.75
258 CD8+ lymphocytes participate in the development of chronic rejection. J Heart Lung Transplant 2001 0.75
259 Tears as carriers of antibodies. II. Charge heterogeneity of IgG antibodies in rabbit tears. Int Arch Allergy Appl Immunol 1968 0.75
260 Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistance. J Urol 1993 0.75
261 Inosine-coated bacteriophage T 4 . Biochim Biophys Acta 1971 0.75
262 Prolonged asymptomatic states in HIV-seropositive persons with fewer than 50 CD4+ T cells per MM3. Psychoneuroimmunologic findings. Ann N Y Acad Sci 1994 0.75
263 Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells. Transplant Proc 1981 0.75
264 A spontaneous sarcoma dependent on host tumor-specific immune lymphocytes. Bioessays 1989 0.75
265 Blocking of the induction and expression of immunologically functional T lymphocytes by rat antiactivated T-cell serum. Cell Immunol 1982 0.75
266 A "nonidiotypic" inhibition of influenza-immune H-2-restricted CTL by an anti-T cell serum. J Immunol 1980 0.75
267 Surface expression of alien hybrid IE/C antigens on the reticulum cell sarcoma of SJL/J mice. Transplant Proc 1981 0.75